June Seymour
Chief Accounting Officer
Cartesian Therapeutics, Inc. (RNAC)Equibles does not estimate personal net worth.
Get an email with a short summary when Cartesian Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get RNAC alertsAbout June Seymour
June Seymour is recorded as Chief Accounting Officer at Cartesian Therapeutics, Inc. (RNAC). The newest filing on record that lists June Seymour as Chief Accounting Officer at Cartesian Therapeutics, Inc. (RNAC) is dated April 28, 2026. Cartesian Therapeutics, Inc. reported in an 8-K filed October 8, 2025 that June Seymour was appointed Chief Accounting Officer, effective October 27, 2025. Cartesian Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Cartesian Therapeutics, Inc. includes Carsten Brunn (CEO and Board Member), Carsten Brunn, Ph.D. (Chairman), Blaine Davis (CFO and Chief Accounting Officer) and 7 others.
“On October 2, 2025, the Board of Directors (the “Board”) of Cartesian Therapeutics, Inc. (the “Company”) appointed June Seymour as the Company’s Chief Accounting Officer, effective upon the commencement of Ms. Seymour’s full-time employment with the Company on October 27, 2025 (the “Effective Date”).”
Affiliation history
-
Current
Start not stated–present
Last confirmed April 28, 2026
Company network
Leadership on record at Cartesian Therapeutics, Inc.
- Carsten Brunn CEO, Board Member
- Carsten Brunn, Ph.D. Chairman
- Blaine Davis CFO, Chief Accounting Officer
- Kevin Tan CFO
- Metin Kurtoglu COO
- Metin Kurtoglu, M.D., Ph.D. COO
- Adrian Bot Board Member
- Adrian Bot, M.D., Ph.D. Board Member
- Carrie S. Cox Board Member
- Kemal Malik Board Member